Immatics (IMTX) Net Margin (2019 - 2025)

Immatics (IMTX) reported Net Margin of 179.29% for Q4 2025, down 25905.0% on a YoY basis from N/an in Q4 2024, and up 81.69% sequentially from 979.35% in Q3 2025.

Immatics (IMTX) Net Margin (2019 - 2025) Analysis & Trends

Immatics (IMTX) has 7 years of Net Margin data on file, last reported at 179.29% in Q4 2025.

  • For the quarter ending Q4 2025, Net Margin fell 25905.0% year-over-year to 179.29%; the trailing twelve-month figure through Dec 2025 stood at 419.72% (down 42857.0% YoY), and the FY2025 full-year result was 407.01%, down 41677.0% from the prior year.
  • Net Margin grew to 179.29% in Q4 2025, from 979.35% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 83.24% in Q1 2022 to a low of 1527.34% in Q2 2025.
  • A 5-year average of 256.6% and a median of 120.85% in 2022 frame the typical range for Net Margin.
  • Across the five-year window, Net Margin surged 166083 bps in 2021 and slumped 143141 bps in 2025, its largest moves.
  • Tracing IMTX's Net Margin over 5 years: stood at 106.74% in 2021, then surged by 106 bps to 5.89% in 2022, then plunged by 2889 bps to 164.24% in 2023, then surged by 149 bps to 79.75% in 2024, then tumbled by 325 bps to 179.29% in 2025.
  • Business Quant data shows IMTX's Net Margin at 179.29% in Q4 2025, 979.35% in Q3 2025, and 1527.34% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Immatics 1.14 Bn 1.14 Bn - -179.29%

Historic Data

Download Data
DateValue
Dec 31, 2025 -179.29%
Sep 30, 2025 -979.35%
Jun 30, 2025 -1,527.34%
Mar 31, 2025 -225.18%
Dec 31, 2024 79.75%
Sep 30, 2024 -24.53%
Jun 30, 2024 -95.93%
Mar 31, 2024 0.00%
Dec 31, 2023 -164.24%
Sep 30, 2023 -447.00%
Jun 30, 2023 -110.09%
Mar 31, 2023 0.00%
Dec 31, 2022 5.89%
Sep 30, 2022 -131.60%
Jun 30, 2022 -67.91%
Mar 31, 2022 83.24%
Dec 31, 2021 -106.74%
Sep 30, 2021 -422.21%
Jun 30, 2021 -511.35%
Mar 31, 2021 -308.16%